Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung

Cancer

Volumn 98, Issue 5, 2003, Pages 1002-1007

  Uchino, Kazuya ^a,b   Ito, Akihiko ^c   Wakayama, Tomohiko ^d   Koma, Yu Ichiro ^c   Okada, Tomoyo ^e   Ohbayashi, Chiho ^a   Iseki, Shoichi ^d   Kitamura, Yukihiko ^c   Tsubota, Noriaki ^b   Okita, Yutaka ^a   Okada, Morihito ^a,b  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Biomarker; Expression; Prognosis; Pulmonary adenocarcinoma; TSLC1

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; TSLC1 PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GENE CONTROL; GENE TSLC1; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; TREATMENT PLANNING; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOCARCINOMA; BLOTTING, WESTERN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MEMBRANE PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROTEIN BIOSYNTHESIS; PROTEINS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0042388405     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11599     Document Type: Article

References (20)

1. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene. 1990;5:1037-1043.
2. Birrer MJ, Minna JD. Genetic changes in the pathogenesis of lung cancer. Annu Rev Med. 1989;40:305-317.
3. Kishimoto Y, Murakami Y, Shiraishi M, Hayashi K, Sekiya T. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res. 1992;52:4799-4804.
4. Sachse R, Murakami Y, Shiraishi M, Hayashi K, Sekiya T. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung. Oncogene. 1994;9:39-47.
5. Wang SS, Esplin ED, Li JL, et al. Alterations of the PPP2R1B gene in human lung and colon cancer. Science. 1998;282:284-287.
6. Arai Y, Hosoda F, Nakayama K, Ohki M. A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2-q23.3. Genomics. 1996;35:196-206.
7. Kok K, Osinga J, Carritt B, et al. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature. 1987;330:578-581.
8. Tamura K, Zhang X, Murakami Y, et al. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int J Cancer. 1997;74:45-49.
9. Weston A, Willey JC, Modali R, et al. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci U S A. 1989;86:5099-5103.
10. Kuramochi M, Fukuhara H, Nobukuni T, et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet. 2003;27:427-430.
11. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710-1717.
12. Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Operative approach for multiple primary lung carcinomas. J Thorac Cardiovasc Surg. 1998;115:836-840.
13. Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. J Thorac Cardiovasc Surg. 1998;116:949-953.
14. Wakayama T, Ohashi K, Mizuno K, Iseki S. Cloning and characterization of a novel mouse immunoglobulin superfamily gene expressed in early spermatogenic cells. Mol Reprod Dev. 2003;60:158-164.
15. Wakayama T, Koami H, Ariga H, et al. Expression and functional characterization of the adhesion molecule spermatogenic immunoglobulin superfamily (SgIGSF) in the mouse testis. Biol Reprod. 2003;68:1755-1763.
16. Ito A, Jippo T, Wakayama T, et al. SgIGSF: a new mast-cell adhesion molecule used for attachment to fibroblasts and transcriptionally regulated by MITF. Blood. 2003;101:2601-2608.
17. Shimoyama Y, Hirohashi S, Hirano S, et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 1989;49:2128-2133.
18. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451-1455.
19. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991;113:173-185.
20. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol. 1993;5:806-811.